DELAYED CARDIAC TOXICITY IN BREAST CANCER PATIENTS TREATED WITH ADJUVANT OR NEOADJUVANT CHEMOTHERAPY (INCLUDING ANTHRACYCLINES) AND TRASTUZUMAB

被引：0
|
作者：
Mailliez, A. [1 ]
Kotecki, N. [2 ]
Kouakam, C.
Fournier, C.
Bonneterre, J. [2 ]
机构：
[1] Ctr Oscar Lambret, Breast Dept, F-59020 Lille, France
[2] Univ Lille Nord France, Ctr Oscar Lambret, Breast Canc Dept, F-59020 Lille, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [41] Adjuvant Trastuzumab Treatment without Adjuvant Chemotherapy in Early Breast Cancer
    Dall, P.
    Koch, T.
    Lenzen, G.
    Kuhn, T.
    Hielscher, C.
    Reichert, D.
    Maasberg, M.
    Ehscheidt, P.
    Eustermann, H.
    Fischer, G.
    CANCER RESEARCH, 2011, 71
  • [42] Symptom Burden Declines When Breast Cancer Patients Treated with Adjuvant Trastuzumab/Combination Chemotherapy Regimens Enter Trastuzumab Monotherapy Follow
    Houts, A. C.
    Lalla, D.
    Walker, M. S.
    Stepanski, E. J.
    Brammer, M.
    Doan, J. F.
    Schwartzberg, L. S.
    CANCER RESEARCH, 2010, 70
  • [43] Completion and toxicity rates of adjuvant chemotherapy in rectal cancer patients previously treated with neoadjuvant therapy and resection.
    Oxner, C. R.
    Choi, S.
    Hein, M. J.
    Lim, D.
    Shibata, S.
    Pigazzi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [44] Locoregional therapy in breast cancer patients treated with neoadjuvant chemotherapy
    Murchison, Sonja
    Truong, Pauline
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 865 - 875
  • [45] Validating response and toxicity predictions of the "virtual patient" in neoadjuvant and adjuvant breast cancer chemotherapy
    Ariad, S.
    Chan, S.
    Agur, Z.
    EJC SUPPLEMENTS, 2007, 5 (03): : 31 - 32
  • [46] Cardiac monitoring during adjuvant trastuzumab-based chemotherapy among older breast cancer patients.
    Gregor, Mariana Chavez-Mac
    Zhang, Ning
    Niu, Jiangong
    Zhang, Yufeng
    Elting, Linda S.
    Buchholz, Thomas A.
    Valero, Vicente
    Giordano, Sharon Hermes
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer
    Palmieri, Carlo
    Macpherson, Iain R. J.
    Yan, Kelvin
    Ades, Felipe
    Riddle, Pippa
    Ahmed, Riz
    Owadally, Waheeda
    Stanley, Barbara
    Shah, Deep
    Gojis, Ondrej
    Januszewski, Adam
    Lewanski, Conrad
    Asher, Rebecca
    Lythgoe, Daniel
    de Azambuja, Evandro
    Beresford, Mark
    Howell, Sacha J.
    ONCOTARGET, 2016, 7 (11) : 13209 - 13220
  • [48] Radiation treatments may contribute to the development of cardiac dysfunction in breast cancer patients treated with chemotherapy and trastuzumab
    El-Din, M. A. Alm
    Bellon, J. R.
    Strom, E. A.
    Bourgier, C.
    Jagsi, R.
    Niemierko, A.
    Marsiglia, H.
    Pierce, L.
    Buchholz, T. A.
    Taghian, A. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S89 - S90
  • [49] Effect of adjuvant trastuzumab (T) among patients treated with neoadjuvant T-based chemotherapy.
    Chavez-Mac Gregor, Mariana
    Parinyanitikul, Napa
    Mittendorf, Elizabeth Ann
    Lei, Xiudong
    Zhang, Hong
    Buzdar, Aman
    Hunt, Kelly
    Hortobagyi, Gabriel N.
    Valero, Vicente
    Gonzalez-Angulo, Ana M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Predictors of Toxicity and Toxicity Profile of Adjuvant Chemotherapy in Elderly Breast Cancer Patients
    Garg, Praveen
    Rana, Fauzia
    Gupta, Ruchi
    Buzaianu, Elena M.
    Guthrie, Troy H.
    BREAST JOURNAL, 2009, 15 (04): : 404 - 408
12345